Modèles animaux de maladie humaine < Modèles biologiques < Modèles de hasards proportionnels

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Modèles biologiques

Number of relevant bibliographic references: 17.

Ident.	Authors (with country if any)	Title
000984 (2019)	Florian Kleinegger [Autriche] ; Eva Hofer [Autriche] ; Christina Wodlej [Autriche] ; Nicole Golob-Schwarzl [Autriche] ; Anna Maria Birkl-Toeglhofer [Autriche] ; Alexander Stallinger [Autriche] ; Johannes Petzold [Autriche] ; Anna Orlova [Autriche] ; Stefanie Krassnig [Autriche] ; Robert Reihs [Autriche] ; Tobias Niedrist [Autriche] ; Harald Mangge [Autriche] ; Young Nyun Park [Corée du Sud] ; Michael Thalhammer [Autriche] ; Ariane Aigelsreiter [Autriche] ; Sigurd Lax [Autriche] ; Christoph Garbers [Allemagne] ; Peter Fickert [Autriche] ; Stefan Rose-John [Allemagne] ; Richard Moriggl [Autriche] ; Beate Rinner [Autriche] ; Johannes Haybaeck [Allemagne]	Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
001374 (2018)	Carla Bastida ; Virginia Ruiz-Esquide ; Mariona Pascal ; Aurelia H. M. De Vries Schultink ; Jordi Yagüe ; Raimon Sanmartí ; Alwin D. R. Huitema ; Dolors Soy	Fixed dosing of intravenous tocilizumab in rheumatoid arthritis. Results from a population pharmacokinetic analysis
001751 (2017)	Wenrui Hao [États-Unis] ; Hannah M. Komar [États-Unis] ; Phil A. Hart ; Darwin L. Conwell ; Gregory B. Lesinski [États-Unis] ; Avner Friedman [États-Unis]	Mathematical model of chronic pancreatitis.
001F09 (2015)	Patrick M. Glassman [États-Unis] ; Yang Chen [États-Unis] ; Joseph P. Balthasar [États-Unis]	Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys.
001F90 (2015)	Aki Isobe [Japon] ; Kenjiro Sawada [Japon] ; Yasuto Kinose [Japon] ; Chifumi Ohyagi-Hara [Japon] ; Erika Nakatsuka [Japon] ; Hiroshi Makino [Japon] ; Tomonori Ogura [Japon] ; Tomoko Mizuno [Japon] ; Noriko Suzuki [Japon] ; Eiichi Morii [Japon] ; Koji Nakamura [Japon] ; Ikuko Sawada [Japon] ; Aska Toda [Japon] ; Kae Hashimoto [Japon] ; Seiji Mabuchi [Japon] ; Tsuyoshi Ohta [Japon] ; Ken-Ichirou Morishige [Japon] ; Hirohisa Kurachi [Japon] ; Tadashi Kimura [Japon]	Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer.
002413 (2014)	Yuji Yoshida [Japon] ; Toshio Tanaka [Japon]	Interleukin 6 and rheumatoid arthritis.
002477 (2014)	Hye-Lin Kim [Corée du Sud] ; Min-Young Lee ; Sun-Young Park ; Sun-Kyeong Park ; Ji-Hye Byun ; Sunhong Kwon ; Eui-Kyung Lee	Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach.
002783 (2013)	Philipp S. Ritter [Allemagne] ; Karsten Kretschmer ; Andrea Pfennig ; Bettina Soltmann	Disturbed sleep in bipolar disorder is related to an elevation of IL-6 in peripheral monocytes.
002897 (2013)	Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]	Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
002F27 (2013)	Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse]	Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis
003392 (2013)	Peter N. Morcos [États-Unis] ; XIAOPING ZHANG [États-Unis] ; Christine Mcintyre [Royaume-Uni] ; Beate Bittner [Suisse] ; Lucy Rowell [Royaume-Uni] ; Zubair Hussain [Royaume-Uni]	Pharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20
003879 (2011)	Jürgen Scheller [Allemagne] ; Athena Chalaris ; Dirk Schmidt-Arras ; Stefan Rose-John	The pro- and anti-inflammatory properties of the cytokine interleukin-6.
003A76 (2011)	Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis]	Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
003F34 (2009)	Hans Ulrich Scherer [Allemagne] ; Gerd R. Burmester	A clinical perspective of rheumatoid arthritis.
004003 (2009)	Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto	Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody
004115 (2008)	Misato Hashizume [Japon] ; Masahiko Mihara [Japon]	Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
004360 (????)	Howard S. Smith [États-Unis] ; Alyssa R. Smith ; Pya Seidner	Painful rheumatoid arthritis.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Modèles biologiques" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Modèles biologiques" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Modèles biologiques
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021